1-11 of 11
Paola Volpicelli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Event-Free Survival According to Age in Patients with Chronic Myeloid Leukemia Receiving Imatinib Frontline: The Younger, the Later, the Worse?

Roberto Latagliata, Massimo Breccia, MD, Ida Carmosino, Federico Vozella, Federico De Angelis, Chiara Montagna, Maria Lucia De Luca, Gioia Colafigli, Luisa Quattrocchi, Giovanna Loglisci, Angela Romano, Paola Volpicelli, Daniela Diverio, PhD, Marco Mancini, Giuliana Alimena
Journal: Blood
Blood (2015) 126 (23): 4038.
https://doi.org/10.1182/blood.V126.23.4038.4038
Published: 2015
Journal Articles

Exclusion Criteria In The Dasision and Enestnd Trials: Which Could Their Impact Be On The Front-Line Treatment Of a “Real-life” Patient Population With Chronic Myelogenous Leukemia?

Roberto Latagliata, MD, Ida Carmosino, Federico Vozella, Paola Volpicelli, MD, Giuseppina Loglisci, Michelina Santopietro, Adriano Salaroli, MD, Angela Romano, Chiara Montagna, Amanda Roberto, Alessandra Serrao, Daniela Diverio, PhD, Mauro Nanni, PhD, Marco Mancini, Agostino Tafuri, Massimo Breccia, Giuliana Alimena, MD
Journal: Blood
Blood (2013) 122 (21): 4002.
https://doi.org/10.1182/blood.V122.21.4002.4002
Published: 2013
Journal Articles

Incidence of Late Chronic Anemia in Newly Diagnosed Patients with Chronic Myelogenous Leukemia Responsive to Imatinib

Paola Volpicelli, MD, Roberto Latagliata, MD, Massimo Breccia, Federico Vozella, Paola Finsinger, Ida Carmosino, Giuseppina Loglisci, MD, Michelina Santopietro, MD, Adriano Salaroli, Daniela Diverio, PhD, Marco Mancini, MD, Agostino Tafuri, Giuliana Alimena
Journal: Blood
Blood (2012) 120 (21): 3769.
https://doi.org/10.1182/blood.V120.21.3769.3769
Published: 2012
Journal Articles

Delayed Cytogenetic Response and Reduced Rate of Major Molecular Response Associated to Increased Body Mass Index At Baseline in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Imatinib.

Massimo Breccia, Giuseppina Loglisci, MD, Adriano Salaroli, MD, Alessandra Serrao, MD, Paola Volpicelli, MD, Daniela Diverio, PhD, Roberto Latagliata, MD, Giuliana Alimena
Journal: Blood
Blood (2012) 120 (21): 2784.
https://doi.org/10.1182/blood.V120.21.2784.2784
Published: 2012
Journal Articles

Complete Cytogenetic Response After 3 Months Is a Very Early Indicator of Good Response to Imatinib As Front-Line Treatment in Chronic Myelogenous Leukemia,

Roberto Latagliata, Massimo Breccia, Ida Carmosino, Federico Vozella, Paola Volpicelli, Antonietta Ferretti, Giuseppina Loglisci, MD, Michelina Santopietro, Vincenzo Federico, Rosa De Cuia, Daniela Diverio, Mauro Nanni, PhD, Marco Mancini, Giuliana Alimena
Journal: Blood
Blood (2011) 118 (21): 3783.
https://doi.org/10.1182/blood.V118.21.3783.3783
Published: 2011
Journal Articles

Skin Toxicity of Hydroxyurea In Ph- Myeloproliferative Neoplasms: Incidence and Clinical Features

Roberto Latagliata, MD, Michele Cedrone, Nicoletta Villivà, Massimo Breccia, Barbara Anaclerico, Paola Volpicelli, Antonella Ferretti, Stefano Felici, Enrico Montefusco, Elisabetta Abruzzese, Antonio Spadea, Francesca Spirito, Ettore Cotroneo, Marianna De Muro, Luciana Annino, MD, Giuseppe Cimino, MD, Giuliana Alimena, Marco Montanaro, Alessandro Andriani
Journal: Blood
Blood (2010) 116 (21): 3077.
https://doi.org/10.1182/blood.V116.21.3077.3077
Published: 2010
Journal Articles

Imatinib as Front-Line Treatment in Chronic Myelogenous Leukemia: How Important is the Achievement of Complete Cytogenetic Response after 3 Months?

Roberto Latagliata, MD, Massimo Breccia, Ida Carmosino, Federico Vozella, Paola Volpicelli, Caterina Stefanizzi, Michelina Santopietro, Rosa De Cuia, Mauro Nanni, Marco Mancini, Giuliana Alimena
Journal: Blood
Blood (2009) 114 (22): 4271.
https://doi.org/10.1182/blood.V114.22.4271.4271
Published: 2009
Journal Articles

ACUTE PROMYELOCYTIC LEUKEMIA (APL) IN PATIENTS AGED > 70 Years.

Paola Finsinger, Massimo Breccia, Clara Minotti, Ida Carmosino, Laura Cannella, Paola Volpicelli, Federico Vozella, Caterina Stefanizzi, Giuseppina Loglisci, Giuseppe Cimino, Robin Foà, Roberto Latagliata, MD
Journal: Blood
Blood (2009) 114 (22): 4160.
https://doi.org/10.1182/blood.V114.22.4160.4160
Published: 2009
Journal Articles

Clinical Results in Patients with Primary and Secondary Myelofibrosis Treated with Monthly Cycles of Oral Melphalan.

Ida Carmosino, Roberto Latagliata, MD, Massimo Breccia, Laura Cannella, Federico Vozella, Paola Volpicelli, Michelina Santopietro, Antonio Spadea, MD, PhD, Maria Concetta Petti, Giuliana Alimena
Journal: Blood
Blood (2009) 114 (22): 4985.
https://doi.org/10.1182/blood.V114.22.4985.4985
Published: 2009
Journal Articles

Treatment with Imatinib in Very Elderly (> 75 Years) CML Patients.

Roberto Latagli Ata, Massimo Breccia, Simona Sica, Antonio Spadea, MD, PhD, Ada D’Addosio, Ida Carmosino, Silvia De Matteis, Caterina Stefanizzi, Paola Volpicelli, Laura Napoleone, Federico Vozella, Maria Concetta Petti, Giuliana Alimena
Journal: Blood
Blood (2008) 112 (11): 1096.
https://doi.org/10.1182/blood.V112.11.1096.1096
Published: 2008
Journal Articles

Decisional Flow with a Score System To Start Platelet-Lowering Treatment in Patients with Essential Thrombocythemia (ET): Long-Term Results.

Roberto Latagliata, MD, Angela Rago, MD, Antonio Spadea, MD, Cristina Santoro, MD, Ida Carmosino, MD, Massimo Breccia, MD, Laura Napoleone, MD, Angelo Fama, MD, Francesca Biondo, MD, Paola Volpicelli, MD, Maria Concetta Petti, PhD, Giuliana Alimena, PhD, Maria Gabriella Mazzucconi, PhD
Journal: Blood
Blood (2007) 110 (11): 4636.
https://doi.org/10.1182/blood.V110.11.4636.4636
Published: 2007